L-CYSTEINE, S-BENZYL (3-13C) is an amino acid derivative of cysteine featuring a thiol-containing side chain in which the sulfur bears a benzyl group, and the backbone retains the amino and carboxyl functional groups characteristic of amino acids. The benzyl substituent is isotopically labeled at the 3-position with 13C, and the molecule is presented in the L-cysteine stereochemical form while the side-chain thiol is converted from a free thiol to a thioether, reducing its direct thiol reactivity. In peptide and bioconjugation workflows, this protected/modified cysteine analogue is used as a structurally defined building block for controlled incorporation of cysteine-like side-chain chemistry and for isotopic labeling in analytical method development and structural studies.
CAT No: L-Iso-0191
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More